OncoCyte Corp Forecast and Stock Analysis
Technical OCX stock analysis for Thursday May 23, 2019.
|Shorts||2.55% ( 2019-04-15 )|
|Price to book||USD 6.72|
|Next Earnings Date||2019-08-12|
OncoCyte Corp fell by -3.04% in the last day ( Thursday, 23rd May 2019 ) from $4.94 to $4.79 and has now fallen 5 days in a row. During day the stock fluctuated 9.67% from a day low at $4.47 to a day high of $4.90. The price has been going up and down for this period, and there has been a 15.14% gain for the last 2 weeks. Volume has increased in the last day by 63 492 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 194 654 shares bought and sold for approximately $932 393.00.
- 30 day high of the OCX stock price was $5.60 and low was $3.85.
- 90 day high was $5.60 and low was $3.20.
- 52 week high for the OncoCyte Corp - $6.92 and low - $1.17.
OncoCyte Corp lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 40.33% during the next 3 months and, with 90% probability hold a price between $6.20 and $7.79 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Friday May 17, 2019, which indicates further falls until a new bottom pivot has been found. OncoCyte Corp gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". OncoCyte Corp holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $5.07. On a fall, the stock will find some support from the long-term average at approximately $4.44. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSI14 is 58 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $4.25 and $4.15.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, OncoCyte Corp finds support just below today's level at $4.25. If this is broken, then the next support from accumulated volume will be at $4.15 and $3.94.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.43 between high and low, or 9.67%. For the last week, the stock has had a daily average volatility of 8.94%.
Our recommended stoploss: $4.51 (-5.89%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 4 days ago.)
8.94 %Average volatility
Very Low Low Medium High Very High
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|OCX $4.79 ($-0.15 -3.04%)|
OCX is down $0.15 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for OCX based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the OCX analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us